Literature DB >> 32776227

Metastatic head and neck cutaneous basal cell carcinomas: a retrospective observational study.

Karina Furlan1, Vijaya Reddy2, Anas Alabkaa2, Prih Rohra2, Fatima Mir2, Paolo Gattuso2.   

Abstract

Cutaneous basal cell carcinoma is usually an indolent and slow-growing tumor with potential for local invasion and recurrence; however, metastatic events are exceedingly rare. The annual incidence of metastasis is estimated to range between 0.00281 and 0.05%. A retrospective search in the pathology database of a single tertiary institution was performed in the period between 1999 to 2019. Primary cutaneous metastatic basal cell carcinomas had paraffin blocks and glass slides retrieved. A total of 8673 cases was identified. The overall prevalence of metastatic tumors was 0.05% (4/8673). The median patient's age at diagnosis was 61 years old (range 52-79). The most common primary site of tumor was nose (2/4) and the most common histological subtype was infiltrative. The sampled lymph nodes were identified during primary tumor resection, except for 1 patient who had a sentinel lymph node biopsy performed as a surgeon individual decision. One patient had hematogenous spread to the pleura, diagnosed 5 years after diagnosis. In summary, this study adds new data to the current literature in metastatic primary cutaneous basal cell carcinomas and highlights the importance of early diagnosis and appropriate surgical excision in an effort to prevent local advanced disease, recurrence and lymphovascular dissemination.

Entities:  

Keywords:  Head and neck basal cell carcinoma; Lymph node metastasis BCC; Metastatic basal cell carcinoma; Pleural metastasis BCC

Mesh:

Year:  2020        PMID: 32776227     DOI: 10.1007/s00403-020-02120-y

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  4 in total

1.  Management of basal cell carcinoma in adults Clinical practice guidelines.

Authors:  Michel Dandurand; Thomas Petit; Philippe Martel; Bernard Guillot
Journal:  Eur J Dermatol       Date:  2006 Jul-Aug       Impact factor: 3.328

2.  Identifying patients at risk for recurrent or advanced BCC.

Authors:  Omid Hamid; Gary Goldenberg
Journal:  J Drugs Dermatol       Date:  2013-11       Impact factor: 2.114

3.  Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter.

Authors:  Frederick C Morgan; Emily Stamell Ruiz; Pritesh S Karia; Robert J Besaw; Victor A Neel; Chrysalyne D Schmults
Journal:  J Am Acad Dermatol       Date:  2019-10-07       Impact factor: 11.527

4.  Cutaneous Basal Cell Carcinoma with Bone Metastases: An Orthopaedic Case Report.

Authors:  Brianna R Fram; John Strony; Geetha Jagannathan; Scot A Brown
Journal:  Case Rep Orthop       Date:  2019-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.